Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
O2Cure was an Israeli private medical device company focused on long-term blood oxygenators and respiratory assist devices for hospital and potentially home-use settings. Its core technology used carbon nanotube-based gas-exchange components and a low-pressure laminar-flow design intended to oxygenate blood while reducing blood damage and enabling pumpless or lower-intensity respiratory support configurations. Public company databases and secondary profiles describe the company as developing an artificial-lung-related platform rather than commercialized products. Recent registry and market-data sources indicate the company is no longer active as an operating business, despite some databases still showing it as active. Overall, O2Cure appears to have been an early-stage respiratory support device developer rather than a therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on O2Cure.